Respiratory Events Among Premature Infants

Status Completed

Clinical Trial Summary

Assess the burden of disease associated with RSV infection with premature children in an outpatient setting.

Clinical Trial Description

The primary objective of this prospective study is to assess the burden of disease associated with RSV infection, as measured/determined by rates of outpatient medically attended LRI, emergency room visits and hospitalization among preterm infants (32-≤36 wGA) during RSV season, and its medical/health consequences, as measured by wheezing events, the infant's first RSV season, up to May 2009. ;

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Respiratory Syncytial Virus

Clinical Trial Details

NCT number	NCT00889070
Study type	Observational
Source	MedImmune LLC
Contact
Status	Completed
Phase	N/A
Start date	November 2008
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04528719` - A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive	Phase 1
Terminated	`NCT02508194` - A Study to Evaluate the Efficacy of MEDI7510 in Older Adults	Phase 2
Active, not recruiting	`NCT06060457` - A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age	Phase 3
Terminated	`NCT01757496` - Cough Assist in Bronchiolitis	N/A
Completed	`NCT00100373` - RSV Challenge in Healthy Adults	N/A
Completed	`NCT03524118` - Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)	Phase 1/Phase 2
Active, not recruiting	`NCT05572658` - Moderna Vaccine mRNA-1345 Observational Respiratory Syncytial Virus (RSV) Study
Recruiting	`NCT06067230` - A Study to Investigate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-risk Adults	Phase 3
Completed	`NCT00246480` - RSV Disease in the Elderly
Active, not recruiting	`NCT06097299` - A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus	Phase 2
Unknown status	`NCT00613184` - Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses	N/A
Completed	`NCT05559905` - Respiratory Syncytial Virus (RSV) Human Challenge Study of Molnupiravir in Healthy Participants (MK-4482-017)	Phase 2
Active, not recruiting	`NCT05127434` - A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age	Phase 2/Phase 3
Terminated	`NCT04978337` - A Study of Rilematovir (JNJ-53718678) in Adult Outpatients With Respiratory Syncytial Virus (RSV) Infection	Phase 2
Recruiting	`NCT06143046` - A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers	Phase 2
Active, not recruiting	`NCT05397223` - A Study of Modified mRNA Vaccines in Healthy Adults	Phase 1
Completed	`NCT02472548` - A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine	Phase 1
Completed	`NCT01734668` - Sofia RSV FIA Field Study	N/A
Completed	`NCT01562938` - MEDI-557 Adult Dosing	Phase 1
Recruiting	`NCT06325657` - A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants	Phase 3